These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34686232)

  • 1. Screening for active and latent TB among migrants in France.
    Luan L; Fraisse P; Cordel H; Charlois C; Méchaï F; Ibanez G; Hargreaves S; Mechain M; Vignier N
    Int J Tuberc Lung Dis; 2021 Nov; 25(11):903-910. PubMed ID: 34686232
    [No Abstract]   [Full Text] [Related]  

  • 2. Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.
    Margineanu I; Rustage K; Noori T; Zenner D; Greenaway C; Pareek M; Akkerman O; Hayward S; Friedland JS; Goletti D; Stienstra Y; Hargreaves S;
    Euro Surveill; 2022 Mar; 27(12):. PubMed ID: 35332865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
    Kunst H; Burman M; Arnesen TM; Fiebig L; Hergens MP; Kalkouni O; Klinkenberg E; Orcau À; Soini H; Sotgiu G; Zenner D; de Vries G
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):840-851. PubMed ID: 28786791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives.
    Dobler CC; Fox GJ; Douglas P; Viney KA; Ahmad Khan F; Temesgen Z; Marais BJ
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29794133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting.
    Dale KD; Abayawardana MJ; McBryde ES; Trauer JM; Carvalho N
    Am J Epidemiol; 2022 Jan; 191(2):255-270. PubMed ID: 34017976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Zenner D; Hafezi H; Potter J; Capone S; Matteelli A
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):965-976. PubMed ID: 28826445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.
    Usemann J; Ledergerber M; Fink G; Ritz N
    Int J Tuberc Lung Dis; 2019 May; 23(5):579-586. PubMed ID: 31097066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional study of prevalence and risk factors, and a cost-effectiveness evaluation of screening and preventive treatment strategies for latent tuberculosis among migrants in Singapore.
    Lim VW; Wee HL; Lee P; Lin Y; Tan YR; Tan MX; Lin LW; Yap P; Chee CB; Barkham T; Lee V; Chen M; Ong RT
    BMJ Open; 2021 Jul; 11(7):e050629. PubMed ID: 34266845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices.
    Dara M; Solovic I; Sotgiu G; D'Ambrosio L; Centis R; Tran R; Goletti D; Duarte R; Aliberti S; de Benedictis FM; Bothamley G; Schaberg T; Abubakar I; Teixeira V; Ward B; Gratziou C; Migliori GB
    Eur Respir J; 2016 Sep; 48(3):808-17. PubMed ID: 27492827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial.
    Burman M; Copas A; Zenner D; Hickson V; Gosce L; Trathen D; Ashcroft R; Martineau AR; Abubakar I; Griffiths C; Kunst H
    BMC Public Health; 2019 Nov; 19(1):1598. PubMed ID: 31783742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
    Seedat F; Hargreaves S; Nellums LB; Ouyang J; Brown M; Friedland JS
    Lancet Infect Dis; 2018 Sep; 18(9):e259-e271. PubMed ID: 29778396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering multi-disease screening to migrants for latent TB and blood-borne viruses in an emergency department setting: A feasibility study.
    Hargreaves S; Nellums LB; Johnson C; Goldberg J; Pantelidis P; Rahman A; Friedland FMedSci JS
    Travel Med Infect Dis; 2020; 36():101611. PubMed ID: 32126293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practices and attitudes towards tuberculosis and latent tuberculosis infection screening in people living with HIV/AIDS among HIV physicians in Japan.
    Kawatsu L; Kaneko N; Imahashi M; Kamada K; Uchimura K
    AIDS Res Ther; 2022 Dec; 19(1):60. PubMed ID: 36463211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A feasibility study evaluating the uptake, effectiveness and acceptability of routine screening of pregnant migrants for latent tuberculosis infection in antenatal care: a research protocol.
    Rahman A; Thangaratinam S; Copas A; Zenner D; White PJ; Griffiths C; Abubakar I; McCourt C; Kunst H
    BMJ Open; 2022 Apr; 12(4):e058734. PubMed ID: 35379641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans.
    Spruijt I; Haile DT; Erkens C; van den Hof S; Goosen S; Ten Kate A; Teshome H; Karels M; Koenders M; Suurmond J
    BMC Public Health; 2020 Mar; 20(1):315. PubMed ID: 32164637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into culturally appropriate latent tuberculosis infection (LTBI) screening in NSW: perspectives of Indian and Pakistani migrants.
    Hall J; Kabir TM; Shih P; Degeling C
    Aust N Z J Public Health; 2020 Oct; 44(5):353-359. PubMed ID: 32776658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
    Campbell JR; Johnston JC; Cook VJ; Sadatsafavi M; Elwood RK; Marra F
    Emerg Infect Dis; 2019 Apr; 25(4):661-671. PubMed ID: 30882302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.
    Zammarchi L; Casadei G; Strohmeyer M; Bartalesi F; Liendo C; Matteelli A; Bonati M; Gotuzzo E; Bartoloni A;
    BMC Health Serv Res; 2015 Sep; 15():412. PubMed ID: 26399233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis.
    Campbell JR; Johnston JC; Ronald LA; Sadatsafavi M; Balshaw RF; Cook VJ; Levin A; Marra F
    Am J Kidney Dis; 2019 Jan; 73(1):39-50. PubMed ID: 30269868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
    Lönnroth K; Mor Z; Erkens C; Bruchfeld J; Nathavitharana RR; van der Werf MJ; Lange C
    Int J Tuberc Lung Dis; 2017 Jun; 21(6):624-637. PubMed ID: 28482956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.